Search

everythinglearnresearchcommunity

for

Search:↓

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Mice with human skin protein K8 had more skin problems and cancer.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Dermatologists perform most outpatient cosmetic procedures in the U.S., especially on white women aged 40 to 59.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Finasteride may help some women with hair loss, but better options exist.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.